Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

NCT05355766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia
Iron Overload

Interventions

DRUG: CN128 Tablets

Sponsor

Hangzhou Zede Pharma-Tech Co., Ltd.